Application 201295
- Type
- ANDA
- Sponsor
- TRIS PHARMA INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | ACETAMINOPHEN; HYDROCODONE BITARTRATE | SOLUTION;ORAL | 325MG/15ML;7.5MG/15ML | No | No |
| 002 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | ACETAMINOPHEN; HYDROCODONE BITARTRATE | SOLUTION;ORAL | 300MG/15ML;10MG/15ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A201295-001 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | ACETAMINOPHEN; HYDROCODONE BITARTRATE | 325MG/15ML;7.5MG/15ML | SOLUTION / ORAL | 2021-12-30 | ||
| A201295-002 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | ACETAMINOPHEN; HYDROCODONE BITARTRATE | 300MG/15ML;10MG/15ML | SOLUTION / ORAL | 2021-12-30 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-03-09 01:35 UTC | 2022-03 | A201295-001 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | 325MG/15ML;7.5MG/15ML | SOLUTION / ORAL | AA | 2021-12-30 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | A201295-002 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | 300MG/15ML;10MG/15ML | SOLUTION / ORAL | AA | 2021-12-30 | bb7c543d1eb4… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A201295-001 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | 325MG/15ML;7.5MG/15ML | SOLUTION / ORAL | 2021-12-30 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A201295-002 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | 300MG/15ML;10MG/15ML | SOLUTION / ORAL | 2021-12-30 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A201295-001 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | 325MG/15ML;7.5MG/15ML | SOLUTION / ORAL | 2021-12-30 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A201295-002 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | 300MG/15ML;10MG/15ML | SOLUTION / ORAL | 2021-12-30 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A201295-001 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | 325MG/15ML;7.5MG/15ML | SOLUTION / ORAL | 2021-12-30 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A201295-002 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | 300MG/15ML;10MG/15ML | SOLUTION / ORAL | 2021-12-30 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A201295-001 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | 325MG/15ML;7.5MG/15ML | SOLUTION / ORAL | 2021-12-30 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A201295-002 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | 300MG/15ML;10MG/15ML | SOLUTION / ORAL | 2021-12-30 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A201295-001 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | 325MG/15ML;7.5MG/15ML | SOLUTION / ORAL | 2021-12-30 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A201295-002 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | 300MG/15ML;10MG/15ML | SOLUTION / ORAL | 2021-12-30 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A201295-001 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | 325MG/15ML;7.5MG/15ML | SOLUTION / ORAL | 2021-12-30 | a67488948f0b… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A201295-002 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | 300MG/15ML;10MG/15ML | SOLUTION / ORAL | 2021-12-30 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A201295-001 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | 325MG/15ML;7.5MG/15ML | SOLUTION / ORAL | 2021-12-30 | 3f0d92c62455… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A201295-002 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | 300MG/15ML;10MG/15ML | SOLUTION / ORAL | 2021-12-30 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A201295-001 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | 325MG/15ML;7.5MG/15ML | SOLUTION / ORAL | 2021-12-30 | 053a50430f4f… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A201295-002 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | 300MG/15ML;10MG/15ML | SOLUTION / ORAL | 2021-12-30 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A201295-001 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | 325MG/15ML;7.5MG/15ML | SOLUTION / ORAL | 2021-12-30 | 3bdfa0b2c4d7… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A201295-002 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | 300MG/15ML;10MG/15ML | SOLUTION / ORAL | 2021-12-30 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A201295-001 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | 325MG/15ML;7.5MG/15ML | SOLUTION / ORAL | 2021-12-30 | 3a93d1ddd44b… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A201295-002 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | 300MG/15ML;10MG/15ML | SOLUTION / ORAL | 2021-12-30 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A201295-001 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | 325MG/15ML;7.5MG/15ML | SOLUTION / ORAL | 2021-12-30 | f41ea6bd6efb… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A201295-002 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | 300MG/15ML;10MG/15ML | SOLUTION / ORAL | 2021-12-30 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A201295-001 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | 325MG/15ML;7.5MG/15ML | SOLUTION / ORAL | 2021-12-30 | e64feba35796… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A201295-002 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | 300MG/15ML;10MG/15ML | SOLUTION / ORAL | 2021-12-30 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A201295-001 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | 325MG/15ML;7.5MG/15ML | SOLUTION / ORAL | 2021-12-30 | cb3db0bc1861… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A201295-002 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | 300MG/15ML;10MG/15ML | SOLUTION / ORAL | 2021-12-30 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A201295-001 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | 325MG/15ML;7.5MG/15ML | SOLUTION / ORAL | 2021-12-30 | a50c72e98297… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A201295-002 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | 300MG/15ML;10MG/15ML | SOLUTION / ORAL | 2021-12-30 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-04-08 23:34 UTC | 2022-04 | A201295-001 | AA | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A201295-002 | AA | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A201295-001 | AA | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A201295-002 | AA | 1 | 4b0b4de00fa7… |
| 2022-03-09 01:35 UTC | 2022-03 | A201295-001 | AA | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A201295-002 | AA | 1 | bb7c543d1eb4… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| hydrocodone bitartrate and acetaminophen | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | Cranbury Pharmaceuticals, LLC | 93b6dfdf-ba6e-4ea6-ab85-5ac121e33101 | 2026-01-08 | Boxed warning, Warnings, Adverse reactions | 201295 ANDA201295 27808-130 |
| Hydrocodone Bitartrate and Acetaminophen | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | Cranbury Pharmaceuticals, LLC | 57e1fe79-eb60-4f4f-bb38-6df0270d408f | 2026-01-08 | Boxed warning, Warnings, Adverse reactions | 201295 ANDA201295 27808-049 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 27808-049 | Hydrocodone Bitartrate and Acetaminophen | Hydrocodone Bitartrate and Acetaminophen | Tris Pharma Inc | ANDA | Current |
| 27808-130 | hydrocodone bitartrate and acetaminophen | hydrocodone bitartrate and acetaminophen | Tris Pharma Inc | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 76481 | ORIG | 2023-11-07 |